Streetbeat News

Products Services

LLY

PFE

Pfizer Inc. (NYSE:PFE) reported a first-quarter adjusted EPS of $0.82, down 33% year over year but above consensus estimates. Sales fell 20% to $14.9 billion, with significant decreases in Comirnaty and Paxlovid revenues. Despite this, Pfizer beat revenue consensus and reiterated its 2024 revenue forecast of $58.5 billion-$61.5 billion. The company is launching a direct-to-consumer platform for medications, including Paxlovid. Eli Lilly (NYSE:LLY) also embraced a similar direct-to-consumer model earlier.

Portfolio Pulse from Vandana Singh

May 01, 2024 | 2:38 pm

TGT

Starlink, Elon Musk's satellite internet service, is now available for purchase at Target Corporation (NYSE:TGT), both online and not in physical stores, with the same pricing as SpaceX. This expansion into retail, including Target, Best Buy, Costco, and Home Depot, aims to increase Starlink's customer base, which has recently surpassed 2.7 million users. Starlink's move to offer refurbished dishes and a $1 trial in select states further aims to make the service more accessible.

Portfolio Pulse from Chris Katje

May 01, 2024 | 2:20 pm

NCLH

During a conference call, an executive from Norwegian Cruise Line Holdings reported continued healthy demand across all markets, brands, and products, including Europe and Alaska.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:17 pm

GDX

GOLD

SGDM

Barrick Gold Corp (NYSE:GOLD) reported a slight increase in FY24 Q1 revenue to $2.747 billion, in line with consensus, despite a production miss. Gold production decreased by 1% Y/Y, and sales by 5% Y/Y, but the average realized gold price rose by 9% Y/Y. Copper production was flat, while its price declined by 8% Y/Y. Adjusted EPS was $0.19, beating the consensus of $0.15. The company maintains its FY24 outlook, expecting gold production to increase with key projects and has declared a $0.10 dividend per share. Investors can also gain exposure through SGDM and GDX ETFs.

Portfolio Pulse from Lekha Gupta

May 01, 2024 | 2:16 pm

NCLH

During a conference call, an executive from Norwegian Cruise Line Holdings reported that demand for cruise vacations remains at an all-time high, with the company experiencing record booking positions and record advanced ticket sales.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:09 pm

TGTX

TG Therapeutics is in the spotlight due to a blog suggesting its strong sales forecast for a Multiple Sclerosis drug could attract M&A interest. The company's potential to draw suitors is based on the promising outlook for its MS treatment.

Portfolio Pulse from Benzinga Newsdesk

May 01, 2024 | 2:03 pm

AAPL

AMD

AMZN

SMCI

SWKS

Jim Cramer praised Amazon's Q1 performance as 'spectacular', highlighting momentum in EPS, free cash flow, gross margins, and AWS orders. He noted Super Micro Computer and AMD faced challenges despite good performances, and predicted Skyworks Solutions would impact Apple negatively. Amazon's AI and AWS businesses showed significant revenue, AMD's Q1 exceeded expectations with record data center revenue, but faced lower future revenue guidance. Skyworks exceeded Q2 earnings expectations, yet faced analyst forecast cuts.

Portfolio Pulse from Rounak Jain

May 01, 2024 | 1:56 pm

BNTX

GSK

PFE

GSK Plc reported a 10% year-over-year increase in first-quarter sales, reaching $9.33 billion, driven by strong demand for vaccines and asthma drugs. Vaccine sales rose 16%, with Shingrix and Arexvy showing significant growth. Specialty Medicine sales, including HIV, respiratory/immunology, and oncology, increased by 17%. GSK raised its 2024 outlook, expecting adjusted EPS growth of 8% to 10% and sales growth at the upper end of its 5% to 7% forecast. The company also filed a lawsuit against Pfizer Inc. and BioNTech SE for patent infringement related to mRNA COVID-19 vaccines.

Portfolio Pulse from Vandana Singh

May 01, 2024 | 1:42 pm

PINS

Pinterest Inc (NYSE:PINS) shares surged after reporting strong Q1 earnings and upbeat guidance. Revenue hit $740 million, surpassing estimates of $699.872 million, with a smaller-than-expected EPS loss of 4 cents. Year-over-year, revenues grew nearly 23%, and global monthly active users reached a record 518 million. CEO Bill Ready highlighted significant growth and advancements in AI and shoppability. Q2 revenue is expected to be between $835 million to $850 million, exceeding forecasts. Rosenblatt analyst Barton Crockett upgraded the price target from $45 to $48.

Portfolio Pulse from Adam Eckert

May 01, 2024 | 1:32 pm